(Q40540571)

21 September 2017

DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. (English)

1 reference

21 September 2017

1 reference

Yuqin Qiu

1

1 reference

21 September 2017

Lei Guo

2

1 reference

21 September 2017

Suohui Zhang

3

1 reference

21 September 2017

Bai Xu

4

1 reference

21 September 2017

Yunhua Gao

5

1 reference

21 September 2017

Yan Hu

6

1 reference

21 September 2017

Jun Hou

7

1 reference

21 September 2017

Bingke Bai

8

1 reference

21 September 2017

Honghui Shen

9

1 reference

21 September 2017

Panyong Mao

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

27 January 2015

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

7

1 reference

21 September 2017

2391-2398

1 reference

Liposome-based cationic adjuvant formulations (CAF): past, present, and future

21 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Technical and regulatory hurdles for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Clinical applications of DNA vaccines: current progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Coated microneedles for transdermal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Immune surveillance in the skin: mechanisms and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Dissolving polymer microneedle patches for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Optimization of intradermal vaccination by DNA tattooing in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Microneedle technologies for (trans)dermal drug and vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Enhancing DNA delivery into the skin with a motorized microneedle device

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.992497

10.3109/10717544.2014.992497

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference